Cite
HARVARD Citation
Büchel, G. et al. (2017). Cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP133912. Dalton transactions. 46 (35), pp. 11925-11941. [Online].